These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis. Merello M; Nouzeilles MI; Arce GP; Leiguarda R Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878 [TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease. Diagnosis and the initiation of therapy. Bhat V; Weiner WJ Minerva Med; 2005 Jun; 96(3):145-54. PubMed ID: 16175158 [TBL] [Abstract][Full Text] [Related]
9. Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa. Fertl E; Auff E; Doppelbauer A; Waldhauser F J Neural Transm Park Dis Dement Sect; 1993; 5(3):227-34. PubMed ID: 8369102 [TBL] [Abstract][Full Text] [Related]
10. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease. Quik M; Spokes EG; Mackay AV; Bannister R J Neurol Sci; 1979 Nov; 43(3):429-37. PubMed ID: 521836 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease as a model for changes in dopamine receptor dynamics with aging. Rinne UK Gerontology; 1982; 28 Suppl 1():35-52. PubMed ID: 7044903 [TBL] [Abstract][Full Text] [Related]
12. Binding of 3H-spiperone to human lymphocytes: a biological marker in schizophrenia? Bondy B; Ackenheil M; Elbers R; Fröhler M Psychiatry Res; 1985 May; 15(1):41-8. PubMed ID: 2409568 [TBL] [Abstract][Full Text] [Related]
13. [Acute dopaminergic responsiveness test in diagnosis of Parkinson's disease and Parkinsonian disorders]. Li W; Feng T; Wang YJ; Lin JX; Xu XT Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2347-9. PubMed ID: 19087697 [TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. Burn DJ; Sawle GV; Brooks DJ J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):278-84. PubMed ID: 8158173 [TBL] [Abstract][Full Text] [Related]
15. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875 [TBL] [Abstract][Full Text] [Related]
16. 123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism. Schwarz J; Tatsch K; Gasser T; Arnold G; Pogarell O; Künig G; Oertel WH Mov Disord; 1998 Jan; 13(1):16-9. PubMed ID: 9452320 [TBL] [Abstract][Full Text] [Related]
17. The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes. Zanigni S; Testa C; Calandra-Buonaura G; Sambati L; Guarino M; Gabellini A; Evangelisti S; Cortelli P; Lodi R; Tonon C Parkinsonism Relat Disord; 2015 Aug; 21(8):929-37. PubMed ID: 26077167 [TBL] [Abstract][Full Text] [Related]